secwatch.observer — SEC 8-K summary
======================================

Issuer:     PULSE BIOSCIENCES, INC. (PLSE)
CIK:        0001625101
Form:       8-K/A
Filed at:   2026-03-02T23:59:59+00:00
Accession:  0001437749-26-006269
Event type: leadership
Sentiment:  negative
Materiality: 0.70
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pulse Biosciences CCO Kevin P. Danahy resigns effective immediately
-------------------------------------------------------------------

- Kevin P. Danahy, Chief Commercial Officer, resigned effective February 27, 2026.
- No reason for the resignation was disclosed in the filing.
- No replacement has been named at this time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1625101/000143774926006269/0001437749-26-006269-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1625101/000143774926006269/plse20260228d_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-006269

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer